STAT+

FDA’s Vinay Prasad Resigns: Controversy & Criticism Explained

by

Archyde The Food and Drug Administration experienced a period of significant internal debate and external scrutiny under the leadership of Dr. Vinay Prasad, who recently announced his departure next month. His… You can read the full story here: FDA’s Vinay Prasad Resigns: Controversy & Criticism Explained. Source link

RFK Jr. Team Divided on Pharma & Vaccines at PhRMA Forum

by

Archyde Washington D.C. – A recent forum hosted by the Pharmaceutical Research and Manufacturers of America (PhRMA) revealed a notable divergence in perspectives among key figures within the Biden administration, particularly… You can read the full story here: RFK Jr. Team Divided on Pharma & Vaccines at PhRMA Forum. Source link

Moderna Flu Vaccine: FDA Review Delay & President’s Response

by

Archyde FDA’s Rejection of Moderna’s Flu Vaccine Signals a Potential Shift in Vaccine Regulation Nearly a billion dollars. That’s approximately how much Moderna invested in a Phase 3 clinical trial for… You can read the full story here: Moderna Flu Vaccine: FDA Review Delay & President’s Response. Source link

Trump Administration Pursues New Rebate Pilot to Reform Federal Drug Discount Program

by

Archyde Federal Drug Pricing Overhaul: New Pilot Program Proposed Table of Contents 1. Federal Drug Pricing Overhaul: New Pilot Program Proposed 2. understanding the 340B Program and its Controversies 3. The… You can read the full story here: Trump Administration Pursues New Rebate Pilot to Reform Federal Drug Discount Program. Source link

Trump Rx: Lower Drug Costs – Savings Now Available?

by

Archyde The Illusion of Discount Drugs: Why TrumpRx Misses the Mark and What’s Coming Next Despite President Trump’s claims of “the largest reduction in prescription drug prices in history,” a closer… You can read the full story here: Trump Rx: Lower Drug Costs – Savings Now Available?. Source link